{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T03:03:14Z","timestamp":1772334194946,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s11739-023-03360-2","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T13:01:50Z","timestamp":1689771710000},"page":"1751-1757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Uric acid plasma levels are associated with C-reactive protein concentrations and the extent of coronary artery lesions in patients with acute coronary syndromes"],"prefix":"10.1007","volume":"18","author":[{"given":"Giovanni","family":"Cimmino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Gallinoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"di Serafino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhmetzhan","family":"Sugraliyev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Golino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7818-4952","authenticated-orcid":false,"given":"Plinio","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"3360_CR1","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M, Benetos A, Biffi A, Boavida JM, Capodanno D et al (2021) 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 42:3227\u20133337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484","journal-title":"Eur Heart J"},{"key":"3360_CR2","first-page":"3167","volume":"12","author":"L Li","year":"2020","unstructured":"Li L, Zhang Y, Zeng C (2020) Update on the epidemiology, genetics, and therapeutic options of hyperuricemia. Am J Transl Res 12:3167\u20133181","journal-title":"Am J Transl Res"},{"key":"3360_CR3","doi-asserted-by":"publisher","first-page":"582680","DOI":"10.3389\/fphar.2020.582680","volume":"11","author":"W Yu","year":"2020","unstructured":"Yu W, Cheng JD (2020) Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective. Front Pharmacol 11:582680. https:\/\/doi.org\/10.3389\/fphar.2020.582680","journal-title":"Front Pharmacol"},{"key":"3360_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejim.2023.02.001","volume":"112","author":"X Tian","year":"2023","unstructured":"Tian X, Chen S, Zhang Y, Zhang X, Xu Q, Wang P, Wu S, Luo Y, Wang A (2023) Serum uric acid variation and the risk of cardiovascular disease: a prospective cohort study. Eur J Intern Med 112:37\u201344. https:\/\/doi.org\/10.1016\/j.ejim.2023.02.001","journal-title":"Eur J Intern Med"},{"key":"3360_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/000327160","volume":"171","author":"M Kanbay","year":"2011","unstructured":"Kanbay M, Afsar B, Covic A (2011) Uric acid as a cardiometabolic risk factor: to be or not to be. Contrib Nephrol 171:62\u201367. https:\/\/doi.org\/10.1159\/000327160","journal-title":"Contrib Nephrol"},{"key":"3360_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","volume":"131","author":"BF Culleton","year":"1999","unstructured":"Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann Intern Med 131:7\u201313. https:\/\/doi.org\/10.7326\/0003-4819-131-1-199907060-00003","journal-title":"Ann Intern Med"},{"key":"3360_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/HYPERTENSIONAHA.117.10370","volume":"71","author":"M Kuwabara","year":"2018","unstructured":"Kuwabara M, Hisatome I, Niwa K, Hara S, Roncal-Jimenez CA, Bjornstad P, Nakagawa T, Andres-Hernando A, Sato Y, Jensen T et al (2018) Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year japanese cohort study. Hypertension 71:78\u201386. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10370","journal-title":"Hypertension"},{"key":"3360_CR8","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/oby.22000","volume":"25","author":"M Kuwabara","year":"2017","unstructured":"Kuwabara M, Kuwabara R, Hisatome I, Niwa K, Roncal-Jimenez CA, Bjornstad P, Andres-Hernando A, Sato Y, Jensen T, Garcia G et al (2017) \u201cMetabolically healthy\u201d obesity and hyperuricemia increase risk for hypertension and diabetes: 5-year japanese cohort study. Obesity 25:1997\u20132008. https:\/\/doi.org\/10.1002\/oby.22000","journal-title":"Obesity"},{"key":"3360_CR9","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1161\/HYPERTENSIONAHA.116.08998","volume":"69","author":"M Kuwabara","year":"2017","unstructured":"Kuwabara M, Niwa K, Hisatome I, Nakagawa T, Roncal-Jimenez CA, Andres-Hernando A, Bjornstad P, Jensen T, Sato Y, Milagres T et al (2017) asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: 5-year japanese cohort study. Hypertension 69:1036\u20131044. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.08998","journal-title":"Hypertension"},{"key":"3360_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijcard.2016.11.268","volume":"231","author":"M Kuwabara","year":"2017","unstructured":"Kuwabara M, Niwa K, Nishihara S, Nishi Y, Takahashi O, Kario K, Yamamoto K, Yamashita T, Hisatome I (2017) Hyperuricemia is an independent competing risk factor for atrial fibrillation. Int J Cardiol 231:137\u2013142. https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.268","journal-title":"Int J Cardiol"},{"key":"3360_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/eurjhf\/hft132","volume":"16","author":"H Huang","year":"2014","unstructured":"Huang H, Huang B, Li Y, Huang Y, Li J, Yao H, Jing X, Chen J, Wang J (2014) Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail 16:15\u201324. https:\/\/doi.org\/10.1093\/eurjhf\/hft132","journal-title":"Eur J Heart Fail"},{"key":"3360_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/heartjnl-2012-302535","volume":"99","author":"M Kanbay","year":"2013","unstructured":"Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759\u2013766. https:\/\/doi.org\/10.1136\/heartjnl-2012-302535","journal-title":"Heart"},{"key":"3360_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.31083\/j.rcm2203108","volume":"22","author":"N Katsiki","year":"2021","unstructured":"Katsiki N, Kouvari M, Panagiotakos DB, Borghi C, Chrysohoou C, Mikhailidis DP, Pitsavos C (2021) The association between serum uric acid levels and 10-year cardiovascular disease incidence: results from the ATTICA prospective study. Rev Cardiovasc Med 22:991\u20131001. https:\/\/doi.org\/10.31083\/j.rcm2203108","journal-title":"Rev Cardiovasc Med"},{"key":"3360_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejim.2020.10.001","volume":"84","author":"LD Browne","year":"2021","unstructured":"Browne LD, Jaouimaa FZ, Walsh C, Perez-Ruiz F, Richette P, Burke K, Stack AG (2021) Serum uric acid and mortality thresholds among men and women in the Irish health system: a cohort study. Eur J Intern Med 84:46\u201355. https:\/\/doi.org\/10.1016\/j.ejim.2020.10.001","journal-title":"Eur J Intern Med"},{"key":"3360_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejim.2022.01.018","volume":"99","author":"P Rebora","year":"2022","unstructured":"Rebora P, Centola M, Morici N, Sacco A, Occhino G, Viola G, Oreglia J, Castini D, Persampieri S, Sabatelli L et al (2022) Uric acid associated with acute heart failure presentation in acute coronary syndrome patients. Eur J Intern Med 99:30\u201337. https:\/\/doi.org\/10.1016\/j.ejim.2022.01.018","journal-title":"Eur J Intern Med"},{"key":"3360_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/01.cir.0000022140.61460.1d","volume":"106","author":"CA Farquharson","year":"2002","unstructured":"Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD (2002) Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106:221\u2013226. https:\/\/doi.org\/10.1161\/01.cir.0000022140.61460.1d","journal-title":"Circulation"},{"key":"3360_CR17","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jacc.2012.09.066","volume":"61","author":"S Rekhraj","year":"2013","unstructured":"Rekhraj S, Gandy SJ, Szwejkowski BR, Nadir MA, Noman A, Houston JG, Lang CC, George J, Struthers AD (2013) High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease. J Am Coll Cardiol 61:926\u2013932. https:\/\/doi.org\/10.1016\/j.jacc.2012.09.066","journal-title":"J Am Coll Cardiol"},{"key":"3360_CR18","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.jacc.2013.07.074","volume":"62","author":"BR Szwejkowski","year":"2013","unstructured":"Szwejkowski BR, Gandy SJ, Rekhraj S, Houston JG, Lang CC, Morris AD, George J, Struthers AD (2013) Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy. J Am Coll Cardiol 62:2284\u20132293. https:\/\/doi.org\/10.1016\/j.jacc.2013.07.074","journal-title":"J Am Coll Cardiol"},{"key":"3360_CR19","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/febs.14768","volume":"286","author":"J Lu","year":"2019","unstructured":"Lu J, Sun M, Wu X, Yuan X, Liu Z, Qu X, Ji X, Merriman TR, Li C (2019) Urate-lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse model of induced carotid atherosclerosis. FEBS J 286:1346\u20131359. https:\/\/doi.org\/10.1111\/febs.14768","journal-title":"FEBS J"},{"key":"3360_CR20","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3892\/ijmm.2015.2148","volume":"35","author":"J Xiao","year":"2015","unstructured":"Xiao J, Zhang XL, Fu C, Han R, Chen W, Lu Y, Ye Z (2015) Soluble uric acid increases NALP3 inflammasome and interleukin-1beta expression in human primary renal proximal tubule epithelial cells through the Toll-like receptor 4-mediated pathway. Int J Mol Med 35:1347\u20131354. https:\/\/doi.org\/10.3892\/ijmm.2015.2148","journal-title":"Int J Mol Med"},{"key":"3360_CR21","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1159\/000487356","volume":"45","author":"Z Li","year":"2018","unstructured":"Li Z, Shen Y, Chen Y, Zhang G, Cheng J, Wang W (2018) High uric acid inhibits cardiomyocyte viability through the ERK\/P38 pathway via oxidative stress. Cell Physiol Biochem 45:1156\u20131164. https:\/\/doi.org\/10.1159\/000487356","journal-title":"Cell Physiol Biochem"},{"key":"3360_CR22","doi-asserted-by":"publisher","first-page":"e0147737","DOI":"10.1371\/journal.pone.0147737","volume":"11","author":"L Zhi","year":"2016","unstructured":"Zhi L, Yuzhang Z, Tianliang H, Hisatome I, Yamamoto T, Jidong C (2016) High uric acid induces insulin resistance in cardiomyocytes in vitro and in vivo. PloS one 11:e0147737. https:\/\/doi.org\/10.1371\/journal.pone.0147737","journal-title":"PloS one"},{"key":"3360_CR23","doi-asserted-by":"publisher","first-page":"e003659","DOI":"10.1136\/bmjopen-2013-003659","volume":"3","author":"T Maruhashi","year":"2013","unstructured":"Maruhashi T, Nakashima A, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Hidaka T et al (2013) Hyperuricemia is independently associated with endothelial dysfunction in postmenopausal women but not in premenopausal women. BMJ open 3:e003659. https:\/\/doi.org\/10.1136\/bmjopen-2013-003659","journal-title":"BMJ open"},{"key":"3360_CR24","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1159\/000488048","volume":"45","author":"M Yan","year":"2018","unstructured":"Yan M, Chen K, He L, Li S, Huang D, Li J (2018) Uric acid induces cardiomyocyte apoptosis via activation of calpain-1 and endoplasmic reticulum stress. Cell Physiol Biochem 45:2122\u20132135. https:\/\/doi.org\/10.1159\/000488048","journal-title":"Cell Physiol Biochem"},{"key":"3360_CR25","doi-asserted-by":"publisher","DOI":"10.1055\/a-1947-7716","author":"G Cimmino","year":"2022","unstructured":"Cimmino G, Conte S, Marra L, Morello A, Morello M, De Rosa G, Pepe M, Sugralyev A, Golino P, Cirillo P (2022) Uric Acid induces a pro-atherothrombotic phenotype in human endothelial cells by imbalancing TF\/TFPI pathway. Thromb Haemost. https:\/\/doi.org\/10.1055\/a-1947-7716","journal-title":"Thromb Haemost"},{"key":"3360_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ekir.2022.11.016","volume":"8","author":"RJ Johnson","year":"2023","unstructured":"Johnson RJ, Sanchez Lozada LG, Lanaspa MA, Piani F, Borghi C (2023) Uric acid and chronic kidney disease: still more to do. Kidney Int Rep 8:229\u2013239. https:\/\/doi.org\/10.1016\/j.ekir.2022.11.016","journal-title":"Kidney Int Rep"},{"key":"3360_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","volume":"213","author":"J Maiuolo","year":"2016","unstructured":"Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V (2016) Regulation of uric acid metabolism and excretion. Int J Cardiol 213:8\u201314. https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.109","journal-title":"Int J Cardiol"},{"key":"3360_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1023\/a:1013735717961","volume":"17","author":"K Sakata","year":"2001","unstructured":"Sakata K, Hashimoto T, Ueshima H, Okayama A, Group NDR (2001) Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980\u20131994. National integrated projects for prospective observation of non-communicable diseases and its trend in the aged. Eur J Epidemiol 17:461\u2013468. https:\/\/doi.org\/10.1023\/a:1013735717961","journal-title":"Eur J Epidemiol"},{"key":"3360_CR29","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/01.HYP.0000248752.08807.4c","volume":"48","author":"TS Perlstein","year":"2006","unstructured":"Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, Weiss ST, Litonjua AA (2006) Uric acid and the development of hypertension: the normative aging study. Hypertension 48:1031\u20131036. https:\/\/doi.org\/10.1161\/01.HYP.0000248752.08807.4c","journal-title":"Hypertension"},{"key":"3360_CR30","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/HYPERTENSIONAHA.122.17956","volume":"79","author":"C Borghi","year":"2022","unstructured":"Borghi C, Agnoletti D, Cicero AFG, Lurbe E, Virdis A (2022) Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk. Hypertension 79:1927\u20131936. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.17956","journal-title":"Hypertension"},{"key":"3360_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ajh\/hpaa044","volume":"33","author":"LG Sanchez-Lozada","year":"2020","unstructured":"Sanchez-Lozada LG, Rodriguez-Iturbe B, Kelley EE, Nakagawa T, Madero M, Feig DI, Borghi C, Piani F, Cara-Fuentes G, Bjornstad P et al (2020) Uric acid and hypertension: an update with recommendations. Am J Hypertens 33:583\u2013594. https:\/\/doi.org\/10.1093\/ajh\/hpaa044","journal-title":"Am J Hypertens"},{"key":"3360_CR32","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2174\/1381612827666210104124320","volume":"27","author":"N Katsiki","year":"2021","unstructured":"Katsiki N, Dimitriadis GD, Mikhailidis DP (2021) Serum uric acid and diabetes: from pathophysiology to cardiovascular disease. Curr Pharm Des 27:1941\u20131951. https:\/\/doi.org\/10.2174\/1381612827666210104124320","journal-title":"Curr Pharm Des"},{"key":"3360_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s40620-019-00615-0","volume":"32","author":"B Afsar","year":"2019","unstructured":"Afsar B, Sag AA, Oztosun C, Kuwabara M, Cozzolino M, Covic A, Kanbay M (2019) The role of uric acid in mineral bone disorders in chronic kidney disease. J Nephrol 32:709\u2013717. https:\/\/doi.org\/10.1007\/s40620-019-00615-0","journal-title":"J Nephrol"},{"key":"3360_CR34","doi-asserted-by":"publisher","first-page":"11735","DOI":"10.1038\/s41598-018-30267-2","volume":"8","author":"T Jensen","year":"2018","unstructured":"Jensen T, Niwa K, Hisatome I, Kanbay M, Andres-Hernando A, Roncal-Jimenez CA, Sato Y, Garcia G, Ohno M, Lanaspa MA et al (2018) Increased serum uric acid over five years is a risk factor for developing fatty liver. Sci Rep 8:11735. https:\/\/doi.org\/10.1038\/s41598-018-30267-2","journal-title":"Sci Rep"},{"key":"3360_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejim.2022.02.017","volume":"99","author":"A Mengozzi","year":"2022","unstructured":"Mengozzi A, Virdis A (2022) Uric acid and cardiovascular risk stratification in the acute coronary syndromes: a friend we should mind. Eur J Intern Med 99:22\u201323. https:\/\/doi.org\/10.1016\/j.ejim.2022.02.017","journal-title":"Eur J Intern Med"},{"key":"3360_CR36","doi-asserted-by":"publisher","first-page":"e18172","DOI":"10.7759\/cureus.18172","volume":"13","author":"J Padda","year":"2021","unstructured":"Padda J, Khalid K, Padda S, Boddeti NL, Malhi BS, Nepal R, Cooper AC, Jean-Charles G (2021) Hyperuricemia and its association with ischemic stroke. Cureus 13:e18172. https:\/\/doi.org\/10.7759\/cureus.18172","journal-title":"Cureus"},{"key":"3360_CR37","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2147\/DMSO.S286299","volume":"14","author":"F Li","year":"2021","unstructured":"Li F, Chen S, Qiu X, Wu J, Tan M, Wang M (2021) Serum uric acid levels and metabolic indices in an obese population: a cross-sectional study. Diabetes Metab Syndr Obes Targets Ther 14:627\u2013635. https:\/\/doi.org\/10.2147\/DMSO.S286299","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"3360_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1573403X12666161014093812","volume":"13","author":"G Cimmino","year":"2017","unstructured":"Cimmino G, Loffredo FS, Morello A, D\u2019Elia S, De Palma R, Cirillo P, Golino P (2017) Immune-inflammatory activation in acute coronary syndromes: a look into the heart of unstable coronary plaque. Curr Cardiol Rev 13:110\u2013117. https:\/\/doi.org\/10.2174\/1573403X12666161014093812","journal-title":"Curr Cardiol Rev"},{"key":"3360_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijcard.2011.05.062","volume":"152","author":"L Forte","year":"2011","unstructured":"Forte L, Cimmino G, Loffredo F, De Palma R, Abbate G, Calabro P, Ingrosso D, Galletti P, Carangio C, Casillo B et al (2011) C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. Int J Cardiol 152:7\u201312. https:\/\/doi.org\/10.1016\/j.ijcard.2011.05.062","journal-title":"Int J Cardiol"},{"key":"3360_CR40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1600-0609.2006.00808.x","volume":"78","author":"HD Danenberg","year":"2007","unstructured":"Danenberg HD, Kantak N, Grad E, Swaminathan RV, Lotan C, Edelman ER (2007) C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy. Eur J Haematol 78:246\u2013252. https:\/\/doi.org\/10.1111\/j.1600-0609.2006.00808.x","journal-title":"Eur J Haematol"},{"key":"3360_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cardiores.2005.05.010","volume":"68","author":"P Cirillo","year":"2005","unstructured":"Cirillo P, Golino P, Calabro P, Cali G, Ragni M, De Rosa S, Cimmino G, Pacileo M, De Palma R, Forte L et al (2005) C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 68:47\u201355. https:\/\/doi.org\/10.1016\/j.cardiores.2005.05.010","journal-title":"Cardiovasc Res"},{"key":"3360_CR42","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.106.643114","volume":"115","author":"N Sattar","year":"2007","unstructured":"Sattar N, Murray HM, McConnachie A, Blauw GJ, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M et al (2007) C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 115:981\u2013989. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.643114","journal-title":"Circulation"},{"key":"3360_CR43","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3305\/nh.2014.29.4.7094","volume":"29","author":"F de Carvalho Vidigal","year":"2014","unstructured":"de Carvalho Vidigal F, de Lima LER, Rosado GP, de Ribeiro RDCL, Franceschini SDCC (2014) Serum uric acid can predict higher C-reactive protein levels in apparently healthy men. Nutricion Hospitalaria 29:935\u2013940. https:\/\/doi.org\/10.3305\/nh.2014.29.4.7094","journal-title":"Nutricion Hospitalaria"},{"key":"3360_CR44","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1681\/ASN.2005050572","volume":"16","author":"DH Kang","year":"2005","unstructured":"Kang DH, Park SK, Lee IK, Johnson RJ (2005) Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16:3553\u20133562. https:\/\/doi.org\/10.1681\/ASN.2005050572","journal-title":"J Am Soc Nephrol"},{"key":"3360_CR45","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","volume":"27","author":"C Ruggiero","year":"2006","unstructured":"Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L (2006) Uric acid and inflammatory markers. Eur Heart J 27:1174\u20131181. https:\/\/doi.org\/10.1093\/eurheartj\/ehi879","journal-title":"Eur Heart J"},{"key":"3360_CR46","first-page":"457","volume":"70","author":"T Pawlowski","year":"2012","unstructured":"Pawlowski T, Prati F, Capodanno D, Tamburino C, Gil RJ (2012) Initial troponin level may predict thrombus burden in patients with acute coronary syndrome. Optical coherence tomography study. Kardiologia Polska 70:457\u2013462","journal-title":"Kardiologia Polska"},{"key":"3360_CR47","doi-asserted-by":"publisher","first-page":"CD00334","DOI":"10.1002\/14651858.CD003334.pub2","volume":"12","author":"J Wasiak","year":"2012","unstructured":"Wasiak J, Law J, Watson P, Spinks A (2012) Percutaneous transluminal rotational atherectomy for coronary artery disease. Cochrane Database Syst Rev 12:CD00334. https:\/\/doi.org\/10.1002\/14651858.CD003334.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"3360_CR48","doi-asserted-by":"publisher","first-page":"7919165","DOI":"10.1155\/2018\/7919165","volume":"2018","author":"D Zhang","year":"2018","unstructured":"Zhang D, Zhang R, Wang N, Lin L, Yu B (2018) Correlation of serum uric acid levels with nonculprit plaque instability in patients with acute coronary syndromes: a 3-vessel optical coherence tomography study. Biomed Res Int 2018:7919165. https:\/\/doi.org\/10.1155\/2018\/7919165","journal-title":"Biomed Res Int"},{"key":"3360_CR49","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1536\/ihj.21-826","volume":"63","author":"X Chu","year":"2022","unstructured":"Chu X, Lu Y, Mei M, Peng P, Zhao Y, Fu G, Qiu F, Jin C (2022) Correlation between serum uric acid levels and coronary plaque characteristics on optical coherence tomography. Int Heart J 63:806\u2013813. https:\/\/doi.org\/10.1536\/ihj.21-826","journal-title":"Int Heart J"},{"key":"3360_CR50","doi-asserted-by":"publisher","first-page":"e13074","DOI":"10.1111\/eci.13074","volume":"49","author":"C He","year":"2019","unstructured":"He C, Lin P, Liu W, Fang K (2019) Prognostic value of hyperuricemia in patients with acute coronary syndrome: a meta-analysis. Eur J Clin Investig 49:e13074. https:\/\/doi.org\/10.1111\/eci.13074","journal-title":"Eur J Clin Investig"},{"key":"3360_CR51","doi-asserted-by":"publisher","first-page":"976190","DOI":"10.3389\/fphys.2022.976190","volume":"13","author":"W Zu","year":"2022","unstructured":"Zu W, Li CC, Wang XY, Li QS, Liu B (2022) Association of uric acid levels with cardiac syndrome X: a meta-analysis. Front Physiol 13:976190. https:\/\/doi.org\/10.3389\/fphys.2022.976190","journal-title":"Front Physiol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-023-03360-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-023-03360-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-023-03360-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T08:27:34Z","timestamp":1694766454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-023-03360-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["3360"],"URL":"https:\/\/doi.org\/10.1007\/s11739-023-03360-2","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"assertion":[{"value":"31 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the local Ethics Committee for retrospective evaluation of medical records.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}